Combination of Doxorubicin and Antiangiogenic Agents in Drug-Eluting Beads: In Vitro Loading and Release Dynamics in View of a Novel Therapeutic Approach for Hepatocellular Carcinoma
ConclusionsDoxorubicin may be combined with antiangiogenic drugs with satisfactory in vitro loading and release outcomes and effect on cellular lines.Graphical Abstract
Source: CardioVascular and Interventional Radiology - Category: Radiology Source Type: research
More News: Cancer & Oncology | Carcinoma | Cardiology | Cardiovascular | Heart | Hepatocellular Carcinoma | Liver Cancer | Radiology | Study